Holger Weis
Chairman at ALAUNOS THERAPEUTICS, INC.
Net worth: 21 914 $ as of 2024-03-30
Profile
Holger Weis is the founder and currently holds the position of President & Principal at Weis Advisors, Inc., which was founded in 2018.
He is also currently serving as Chairman at Alaunos Therapeutics, Inc. since 2020 and as an Independent Director at Jupiter Neurosciences, Inc. since 2021.
In his former positions, Mr. Weis served as Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021, Senior Manager at Ernst & Young LLP from 1986 to 2000, Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005, President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017, Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010, and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011.
Mr. Weis obtained his undergraduate degree from the University of Georgia in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-05 | 12,107 ( 0.08% ) | 21 914 $ | 2024-03-30 |
Holger Weis active positions
| Companies | Position | Start |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chairman | 2023-09-21 |
| JUPITER NEUROSCIENCES, INC. | Director/Board Member | 2021-09-07 |
Former positions of Holger Weis
| Companies | Position | End |
|---|---|---|
DemeRx, Inc.
 DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | President | 2017-07-23 |
GMP Cos., Inc.
 GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Director of Finance/CFO | 2004-12-31 |
Training of Holger Weis
| University of Georgia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| JUPITER NEUROSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Health Technology |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Health Technology |
- Stock Market
- Insiders
- Holger Weis
